NCT01195532 An Open-randomized, Balanced, Crossover Bioequivalence Study to Compare One MR Tablet of 60 mg Gliclazide and Two MR Tablets of 30 mg Gliclazide in Healthy Subjects Status UNKNOWN Phase N/A
NCT01193387 Comparison of Two Identical NN1250 Formulations in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01192373 Modulation of Free Fatty Acids in Heart Failure Patients With Diabetes: "Effect on Left Ventricular Function" Status COMPLETED Phase PHASE2
NCT01186562 Sitagliptin Therapy to Improve Outcomes After Islet Autotransplant Status COMPLETED Phase PHASE4
NCT01186107 Comparison of Zotarolimus-Eluting Stent vs Sirolimus-Eluting Stent for Diabetic Patients Status COMPLETED Phase PHASE4
NCT01186003 Effectiveness of Adding Subcutaneous Long-Acting Detemir to Insulin Drip Therapy Compared With Standard Insulin Drip Therapy Status COMPLETED Phase NA
NCT01185574 Vitamin D for Improving Metabolic Control and Depressive Symptoms Status COMPLETED Phase NA
NCT01180530 Observational Study of NovoPen Echo® on Safety and Treatment Satisfaction in Children and Adolescents With Type 1 Diabetes Status COMPLETED Phase N/A
NCT01179048 Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results Status COMPLETED Phase PHASE3
NCT01175486 Thiazolidinedione (TZD) on the Diabetic Retinopathy and Nephropathy Status UNKNOWN Phase PHASE4
NCT01174381 The Use of a Community-based Organization to Change Lifestyle Characteristics Related to Non Communicable Diseases Status COMPLETED Phase NA
NCT01174303 A Trial Investigating the Exposure of NN5401 in Young Adults and Elderly Subjects With Type 1 Diabetes Status COMPLETED Phase PHASE1
NCT01173926 Comparison of the Effect of NN5401 With the Effect of NN1250 and Insulin Aspart in Subjects With Type 1 Diabetes Status COMPLETED Phase PHASE1
NCT01173094 Optimized Strategy for Diabetic Patients With Critical Limb Ischemia(Part II) (DCLI-II) Status UNKNOWN Phase PHASE4
NCT01171703 Optimized Strategy for Diabetic Patients With Critical Limb Ischemia(Part I) Status UNKNOWN Phase PHASE4
NCT01170208 Insulin Dosage Software Program for People With Type 1 and Type 2 Diabetes Status COMPLETED Phase NA